发明名称 Use of dienogest in fixed extended cycle hormonal contraceptives
摘要 <p>A hormonal female contraception method involves continuous administration of a single-phase preparation containing dienogest (I) in a daily amount of 0.5-3.0 mg and estradiol (II) in a daily amount of 0.5-3.0 mg (or an estrogenically equivalent amount of another natural or synthetic estrogen) over a time-span of n x 21 days (where n is 2-5), followed by a 7-day pill pause. An independent claim is included for a pharmaceutical package, adapted for oral administration, comprising a single phase preparation as above, the number of individual dose units of the preparation being suitable for carrying out the contraception method as above; and patient instructions for the use of the preparation in the method. ACTIVITY : Antifertility; dermatological; antiseborrheic; gynecological. MECHANISM OF ACTION : Progestogen; estrogen.</p>
申请公布号 EP1655031(A1) 申请公布日期 2006.05.10
申请号 EP20050022033 申请日期 2005.10.10
申请人 SCHERING AG 发明人 SACHSE, ANDREAS
分类号 A61K31/565;A61P5/30;A61P5/34 主分类号 A61K31/565
代理机构 代理人
主权项
地址